Summary

Report Scope
This report is a comprehensive study of the global metabolomics technologies market. Current and historical market revenues are estimated based on product, indication, application and region.
Report Includes
- 32 data tables and 39 additional tables
- An overview of the global market for metabolomics, the study of small molecules, known as metabolites, in cells, biofluids, tissues and organisms
- Analysis of global market trends, featuring revenue data for 2021-2023, estimates for 2024, forecasts for 2029 and projected CAGRs through 2029
- Evaluation of the current market’s size and revenue growth prospects, along with a market share analysis by product, indication, application, and region
- Analysis of the market drivers, restraints and opportunities, and identification of the companies best positioned to meet the demand for metabolics
- A look at ESG trends
- Information on developments in R&D, clinical trials, emerging technologies, and economic trends
- Analysis of key companies’ market shares, proprietary technologies, patents, and alliances
- Profiles of the leading companies, including Agilent Technologies Inc., Bio-Rad Laboratories Inc., Bruker, Danaher Corp., and Merck KGaA

ページTOPに戻る

Table of Contents

Table of Contents
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Chapter 2 Market Overview
Overview
Overview of Metabolomics
Separation Techniques
Detection Techniques
Metabolites and Their Applications
R&D and Regulatory Approval
Supply Chain Analysis
Chapter 3 Market Dynamics
Market Dynamics Snapshot
Market Drivers
Technological Advancements
Increasing Healthcare Expenditure
Expanding Applications Across Industries
Market Restraints
High Cost of Instruments and Services
Complexity of Data Analysis
Standardization and Quality Control Challenges
Limited Biomarker Validation and Clinical Utility
Market Opportunities
Precision Medicine and Personalized Healthcare
Drug Discovery and Development
Biomarker Discovery and Validation
Nutritional Profiling and Functional Foods
Environmental Monitoring and Toxicology
Market Challenges
Data Complexity and Interpretation
Standardization and Quality Assurance
Biomarker Validation and Clinical Translation
Technological Limitations and Costs
Regulatory and Ethical Considerations
Chapter 4 Emerging Technologies and Developments
Introduction
Clinical Trial Analysis
By Study Type
By Status
By Gender
By Interventions
Granted Patents
Introduction
Patent Analysis
Chapter 5 Market Segmentation Analysis
Segmentation Breakdown
Metabolomics Market, by Product
Global Market Analysis and Forecast
Separation Techniques
Detection Techniques
Metabolomics Market, by Indication
Global Market Analysis and Forecast
Cancer
Cardiovascular Disorders
Neurological Disorders
Inborn Errors of Metabolism
Other Diseases Indication
Metabolomics Market, by Application
Global Market Analysis and Forecast
Biomarker Discovery
Drug Discovery
Toxicology Testing
Nutrigenomics
Functional Genomics
Others
Geographic Breakdown
Metabolomics Market, by Region
Global
North America
Europe
Asia-Pacific
Rest of the World
Chapter 6 Competitive Intelligence
Company Share Analysis
Strategic Analysis
Mergers and Acquisitions
Venture Capital Funding
Chapter 7 Appendix
Methodology
Sources
Acronyms
Definitions/Taxonomy
Company Profiles
AGILENT TECHNOLOGIES INC.
BIO-RAD LABORATORIES INC.
BRUKER
DANAHER CORP.
MERCK KGAA
SHIMADZU CORP.
THERMO FISHER SCIENTIFIC INC.
WATERS CORP.